INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773HAB8. A total of 4 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,049,225 | -1.2% | 6,500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $6,124,389 | +20.0% | 6,500,000 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $5,104,121 | -12.1% | 6,500,000 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $5,808,616 | +0.8% | 6,500,000 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $5,764,000 | +26.0% | 6,500,000 | +30.0% | 0.01% | +40.0% |
| Q2 2022 | $4,575,000 | -20.1% | 5,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $5,726,000 | -3.4% | 5,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $5,925,000 | -14.3% | 5,000,000 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $6,912,000 | -21.1% | 5,000,000 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $8,758,000 | -0.3% | 5,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $8,784,000 | +6.1% | 5,000,000 | 0.0% | 0.01% | +14.3% |
| Q4 2020 | $8,277,000 | -22.7% | 5,000,000 | 0.0% | 0.01% | -36.4% |
| Q3 2020 | $10,709,000 | -57.0% | 5,000,000 | 0.0% | 0.01% | -63.3% |
| Q2 2020 | $24,921,000 | +235.1% | 5,000,000 | 0.0% | 0.03% | +150.0% |
| Q1 2020 | $7,437,000 | – | 5,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AQR Arbitrage LLC | 5,000,000 | $4,571,000 | 0.12% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,415,000 | $6,081,000 | 0.06% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $5,726,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |